愛美醫療 FOLD 深 滬
等待開盤 09-18 09:30:00 美东时间
7.925
-0.085
-1.06%
華盛通- 最 高8.12
- 今 開7.99
- 成交量 303.86万股
- 最 低 7.885
- 昨 收 8.01
- 總市值 24.41亿
- 52周最高 12.65
- 市盈率 靜 --
- 換手率 0.99%
- 52周最低 5.51
- 委 比 13.04%
- 總股本 3.08亿
- 歷史最高 25.39
- 量 比 0.87
- 振 幅 2.93%
- 歷史最低 1.765
- 每 手 1
- 風險率 1.83%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Analysts Offer Insights on Healthcare Companies: Amicus (FOLD) and Protara Therapeutics (TARA)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
09-17 16:50
Amicus Therapeutics Reports 4-Year Muscle Function And Biomarker Data From PROPEL Study Of Cipaglucosidase Alfa + Miglustat In Late-Onset Pompe Disease
Amicus Therapeutics (NASDAQ:FOLD), today announced the presentation of new 4-year muscle function, muscle strength and biomarker endpoints from the PROPEL open-label extension (OLE) study of cipaglucosidase alfa-atga +
09-08 21:05
仅一名员工，融资5.4亿
“核药”站上了风口。 作者丨王满华 来源丨投中网 一家创业公司想要获得上亿融资，其团队规模的下限是多少？来自挪威的Actithera给出了答案：一名员工足...
08-12 15:00
Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators
NetworkNewsWire Editorial Coverage NEW YORK, Aug. 6, 2025 /PRNewswire/ -- As the American population gets older, chronic and rare diseases are becoming a significant healthcare issue, partic...
08-06 20:30
Amicus Therapeutics Affirms FY2025 Sales Guidance of $607.539M-$644.520M vs $620.675M Est
2025 Financial GuidanceAmicus reiterates its financial guidance for 2025, as follows:Total Revenue Growth115% to 22% Galafold Revenue Growth110% to 15% Pombiliti + Opfolda Revenue Growth150% to 65% Gross
07-31 19:14
Amicus Therapeutics Q2 Adj. EPS $0.01 Beats $(0.11) Estimate, Sales $154.688M Beat $147.399M Estimate
Amicus Therapeutics (NASDAQ:FOLD) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.11) by 109.09 percent. This is a 83.33 percent decrease over earnings of $0.06 per share
07-31 19:06
Earnings Scheduled For July 31, 2025
Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (...
07-31 16:32
Here are the major earnings before the open Thursday
Major earnings expected before the bell on Thursday include: AbbVie (OTC:ABBY) Bristol-Myers Squibb Company (BMY) Mastercard Incorporated (MA) CVS Health Corporation (CVS) Shell plc (SHEL) Other earni...
07-31 06:00
Dimerix Secures Major Licensing Deal with Amicus Therapeutics
Dimerix Limited ( ($AU:DXB) ) just unveiled an update. Dimerix Limited announce...
07-25 07:28
Amicus Therapeutics to Announce Second Quarter 2025 Financial Results on July 31, 2025
Amicus Therapeutics will host a conference call and live audio webcast on July 31, 2025, at 8:30 a.m. ET to discuss Q2 2025 financial results. Participants must register online to receive dial-in details, while webcast access is available via the company's Investor Relations website. An archived webcast and slides will be posted shortly after the event.
07-21 11:00
